Zachary Elliott, PharmD, MBA , Director, Fingerpaint Market Access
Advertisement
Articles by Zachary Elliott, PharmD, MBA , Director, Fingerpaint Market Access
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Merck KGaA, Darmstadt, Germany, Acquires Silence Therapeutics for $1.3 Billion
2
METiS Enters Collaboration with Eli Lilly for Next-Generation Tissue-Specific LNP Delivery Technologies
3
FDA Grants Accelerated Approval to Jemperli for MSI-H/dMMR Locally Advanced Rectal Cancer
4
Hansoh Pharma Enters $15 Billion Collaboration and License Agreement with Roche
5